This company listing is no longer active
BBS-Bioactive Bone Substitutes Oyj Balance Sheet Health
Financial Health criteria checks 1/6
Key information
170.8%
Debt to equity ratio
€6.21m
Debt
| Interest coverage ratio | n/a |
| Cash | €1.24m |
| Equity | €3.63m |
| Total liabilities | €6.87m |
| Total assets | €10.51m |
Recent financial health updates
No updates
Recent updates
No updates
Financial Position Analysis
Short Term Liabilities: BONEHN0122's short term assets (€1.6M) do not cover its short term liabilities (€1.6M).
Long Term Liabilities: BONEHN0122's short term assets (€1.6M) do not cover its long term liabilities (€5.3M).
Debt to Equity History and Analysis
Debt Level: BONEHN0122's net debt to equity ratio (136.7%) is considered high.
Reducing Debt: BONEHN0122's debt to equity ratio has reduced from 173% to 170.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BONEHN0122 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BONEHN0122 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 16.4% each year